• SLOGAN
  • Image 1
  • Image 2

hotline-bvtanchau

Giờ Khám Bệnh

- SÁNG:    7h00 - 11h00
- CHIỀU: 13h00 - 17h00


Khám bệnh từ thứ 2 đến thứ 6 hàng tuần (trừ ngày lễ, tết)

Đăng Ký

KHÁM CHỮA BỆNH

TRỰC TUYẾN

 

Vui lòng đăng ký trước khi khám ít nhất 1 ngày để được phục vụ tốt nhất

(Quét mã QR)

android - bvtc

(Thiết bị Android)

 

ios - bvtanchau

(Thiết bị iOS)

 

Lượt Truy cập

1673371
Hôm nay
Tất cả
797
1673371

IP: 18.119.157.117
2024-12-23 08:31

Int J Tuberc Lung Dis. 2013 Feb;17(2):153-62. doi: 10.5588/ijtld.12.0401.

Lee JSPark DAHong YJo KWLee SWHuh JWOh YMLee SD.

Source: Department of Pulmonary and Critical Care Medicine, and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

BACKGROUND:

Exacerbations contribute substantially to the morbidity and mortality associated with chronic obstructive pulmonary disease (COPD).

OBJECTIVES:

To assess whether prophylactic antibiotic treatment reduces exacerbations in patients with COPD and/or chronic bronchitis.

METHODS:

Medline, EMBASE, Cochrane Central Register of Controlled Trials, Koreamed and references from relevant publications were searched up to October 2011. Randomised controlled trials comparing the effect of any prophylactic antibiotics with placebo for at least 3 months were included. The co-primary outcomes were the frequency of exacerbations of COPD or chronic bronchitis and adverse treatment events.

RESULTS:

A total of 19 trials involving 3932 subjects were included in the analysis: 5 recent trials included patients with moderate to severe COPD, whereas 14 older trials included patients with chronic bronchitis. The use of antibiotics significantly reduced the rate of COPD exacerbations (risk ratio [RR] 0.73, 95%CI 0.66-0.82), the number of chronic bronchitis exacerbations (standardised mean difference -0.23, 95%CI -0.35--0.11) and the proportion of patients with exacerbations of chronic bronchitis (RR 0.93, 95%CI 0.87-0.99).

CONCLUSION:

Prophylactic antibiotic treatment has a significant effect in reducing exacerbations in patients with COPD and/or chronic bronchitis.